Trial intelligence / Profile preview

Intrathecal Hydromorphone vs Intrathecal Morphine for Analgesia After Laparoscopic Hepatectomy

ChiCTR2300070888Phase 4Not yet recruiting

Sponsor
Sir Run-Run Shaw Hospital
Start
Apr 2023
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in hepatic neoplasm comparing Intrathecal hydromorphone 75 μg with Intrathecal morphine 150 μg (2 arms). Primary endpoint: VAS pain score. Planned start Apr 2023; status: not yet recruiting.

02

Drugs

hydromorphonemorphine
03

Conditions

hepatic neoplasm

Beyond the preview

Go deeper on ChiCTR2300070888.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300070888.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call